186 related articles for article (PubMed ID: 17458610)
41. Survival after pancreaticoduodenectomy for periampullary adenocarcinoma: an update.
van Geenen RC; van Gulik TM; Offerhaus GJ; de Wit LT; Busch OR; Obertop H; Gouma DJ
Eur J Surg Oncol; 2001 Sep; 27(6):549-57. PubMed ID: 11520088
[TBL] [Abstract][Full Text] [Related]
42. Factors influencing survival after resection for ductal adenocarcinoma of the head of the pancreas.
Benassai G; Mastrorilli M; Quarto G; Cappiello A; Giani U; Forestieri P; Mazzeo F
J Surg Oncol; 2000 Apr; 73(4):212-8. PubMed ID: 10797334
[TBL] [Abstract][Full Text] [Related]
43. Is it time to stop checking frozen section neck margins during pancreaticoduodenectomy?
Lad NL; Squires MH; Maithel SK; Fisher SB; Mehta VV; Cardona K; Russell MC; Staley CA; Adsay NV; Kooby DA
Ann Surg Oncol; 2013 Oct; 20(11):3626-33. PubMed ID: 23838908
[TBL] [Abstract][Full Text] [Related]
44. Detrimental effect of postoperative complications on oncologic efficacy of R0 pancreatectomy in ductal adenocarcinoma of the pancreas.
Kang CM; Kim DH; Choi GH; Kim KS; Choi JS; Lee WJ
J Gastrointest Surg; 2009 May; 13(5):907-14. PubMed ID: 19224295
[TBL] [Abstract][Full Text] [Related]
45. Significance of common hepatic artery lymph node metastases during pancreaticoduodenectomy for pancreatic head adenocarcinoma.
Cordera F; Arciero CA; Li T; Watson JC; Hoffman JP
Ann Surg Oncol; 2007 Aug; 14(8):2330-6. PubMed ID: 17492334
[TBL] [Abstract][Full Text] [Related]
46. Adenocarcinoma of the pancreas: Does prognosis depend on mode of lymph node invasion?
Buc E; Couvelard A; Kwiatkowski F; Dokmak S; Ruszniewski P; Hammel P; Belghiti J; Sauvanet A
Eur J Surg Oncol; 2014 Nov; 40(11):1578-85. PubMed ID: 24923739
[TBL] [Abstract][Full Text] [Related]
47. The impact of margin status determined by the one-millimeter rule on tumor recurrence and survival following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
Nitta T; Nakamura T; Mitsuhashi T; Asano T; Okamura K; Tsuchikawa T; Tamoto E; Murakami S; Noji T; Kurashima Y; Ebihara Y; Nakanishi Y; Shichinohe T; Hirano S
Surg Today; 2017 Apr; 47(4):490-497. PubMed ID: 27677294
[TBL] [Abstract][Full Text] [Related]
48. Is the involvement of the hepatic artery lymph node a poor prognostic factor in pancreatic adenocarcinoma?
Rodrigues V; Dopazo C; Pando E; Blanco L; Caralt M; Gómez-Gavara C; Bilbao I; Salcedo MT; Balsells J; Charco R
Cir Esp (Engl Ed); 2020 Apr; 98(4):204-211. PubMed ID: 31839175
[TBL] [Abstract][Full Text] [Related]
49. [Does the extent of lymph node dissection have an effect on morbidity and prognosis after resection of the head of the pancreas for ductal or periampullary pancreatic carcinoma?].
Böttger T; Boddin J; Küchle R; Junginger T
Langenbecks Arch Chir; 1997; 382(4):209-15. PubMed ID: 9445967
[TBL] [Abstract][Full Text] [Related]
50. Positive mobilization margins alone do not influence survival following pancreatico-duodenectomy for pancreatic ductal adenocarcinoma.
Jamieson NB; Foulis AK; Oien KA; Going JJ; Glen P; Dickson EJ; Imrie CW; McKay CJ; Carter R
Ann Surg; 2010 Jun; 251(6):1003-10. PubMed ID: 20485150
[TBL] [Abstract][Full Text] [Related]
51. Perineural and intraneural invasion in posttherapy pancreaticoduodenectomy specimens predicts poor prognosis in patients with pancreatic ductal adenocarcinoma.
Chatterjee D; Katz MH; Rashid A; Wang H; Iuga AC; Varadhachary GR; Wolff RA; Lee JE; Pisters PW; Crane CH; Gomez HF; Abbruzzese JL; Fleming JB; Wang H
Am J Surg Pathol; 2012 Mar; 36(3):409-17. PubMed ID: 22301497
[TBL] [Abstract][Full Text] [Related]
52. Lymph node involvement beyond peripancreatic region in pancreatic head cancers: when results belie expectations.
Golse N; Lebeau R; Lombard-Bohas C; Hervieu V; Ponchon T; Adham M
Pancreas; 2013 Mar; 42(2):239-48. PubMed ID: 23038054
[TBL] [Abstract][Full Text] [Related]
53. Tumor size is the primary prognosticator for pancreatic cancer after regional pancreatectomy.
Fortner JG; Klimstra DS; Senie RT; Maclean BJ
Ann Surg; 1996 Feb; 223(2):147-53. PubMed ID: 8597508
[TBL] [Abstract][Full Text] [Related]
54. Adjuvant chemoradiotherapy after pancreatic resection for invasive carcinoma associated with intraductal papillary mucinous neoplasm of the pancreas.
Swartz MJ; Hsu CC; Pawlik TM; Winter J; Hruban RH; Guler M; Schulick RD; Cameron JL; Laheru DA; Wolfgang CL; Herman JM
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):839-44. PubMed ID: 19647950
[TBL] [Abstract][Full Text] [Related]
55. Para-aortic lymph node sampling in pancreatic head adenocarcinoma.
Schwarz L; Lupinacci RM; Svrcek M; Lesurtel M; Bubenheim M; Vuarnesson H; Balladur P; Paye F
Br J Surg; 2014 Apr; 101(5):530-8. PubMed ID: 24633831
[TBL] [Abstract][Full Text] [Related]
56. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.
Yeo CJ; Abrams RA; Grochow LB; Sohn TA; Ord SE; Hruban RH; Zahurak ML; Dooley WC; Coleman J; Sauter PK; Pitt HA; Lillemoe KD; Cameron JL
Ann Surg; 1997 May; 225(5):621-33; discussion 633-6. PubMed ID: 9193189
[TBL] [Abstract][Full Text] [Related]
57. Superior Mesenteric Artery Margin of Posttherapy Pancreaticoduodenectomy and Prognosis in Patients With Pancreatic Ductal Adenocarcinoma.
Liu L; Katz MH; Lee SM; Fischer LK; Prakash L; Parker N; Wang H; Varadhachary GR; Wolff RA; Lee JE; Pisters PW; Maitra A; Fleming JB; Estrella J; Rashid A; Wang H
Am J Surg Pathol; 2015 Oct; 39(10):1395-403. PubMed ID: 26200098
[TBL] [Abstract][Full Text] [Related]
58. Preoperative risk factors for para-aortic lymph node positivity in pancreatic cancer.
Okada K; Uemura K; Kondo N; Sumiyoshi T; Seo S; Otsuka H; Serikawa M; Ishii Y; Tsuboi T; Murakami Y; Takahashi S
Pancreatology; 2021 Apr; 21(3):606-612. PubMed ID: 33648880
[TBL] [Abstract][Full Text] [Related]
59. MAPLE-PD trial (Mesenteric Approach vs. Conventional Approach for Pancreatic Cancer during Pancreaticoduodenectomy): study protocol for a multicenter randomized controlled trial of 354 patients with pancreatic ductal adenocarcinoma.
Hirono S; Kawai M; Okada KI; Fujii T; Sho M; Satoi S; Amano R; Eguchi H; Mataki Y; Nakamura M; Matsumoto I; Baba H; Tani M; Kawabata Y; Nagakawa Y; Yamada S; Murakami Y; Shimokawa T; Yamaue H
Trials; 2018 Nov; 19(1):613. PubMed ID: 30409152
[TBL] [Abstract][Full Text] [Related]
60. 1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience.
Winter JM; Cameron JL; Campbell KA; Arnold MA; Chang DC; Coleman J; Hodgin MB; Sauter PK; Hruban RH; Riall TS; Schulick RD; Choti MA; Lillemoe KD; Yeo CJ
J Gastrointest Surg; 2006 Nov; 10(9):1199-210; discussion 1210-1. PubMed ID: 17114007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]